Results 151 to 160 of about 73,125 (286)

Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background Emerging studies indicate that microbes are present in tumor cells and immune cells. Intratumoral microbiota (ITM) constitute an important component of the tumor immune microenvironment (TIME) and have an important impact on tumor progression and treatment. Objective Through the general elaboration of ITM represented by bacteria and
Fengxue Li, Lili Qiao, Xinquan Liang, Yingying Zhang, Ning Liang, Jian Xie, Guodong Deng, Yuying Hao, Pingping Hu, Xue Wu, Fangjie Ding, Can Feng, Yiming Mu, Jiandong Zhang   +13 more
wiley   +1 more source

Risk Factors and Prediction Model for Early‐Onset Immune‐Related Adverse Events in Pan‐Cancer Patients Undergoing Anti‐PD‐(L)1 Therapy: A Retrospective Study in a Tertiary‐Level Hospital

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background Anti‐programmed death 1 (PD‐1) and anti‐programmed death ligand 1 (PD‐L1) immune checkpoint inhibitors (ICIs) have changed the treatment landscape of many advanced malignancies. However, immune‐related adverse events (irAEs) bring great challenges to clinical benefits. The prediction of irAEs is urgently demanded for early detection
Panpan Jiao, Lijuan Xue, Weijuan Tan, Quan Chen, Shan Lin, Min Song, Chunling Ma, Juan Zhan   +7 more
wiley   +1 more source

HBV-DNA [PDF]

, 2019
openaire   +1 more source

Letter: Using Anti‐HBs Titers to Tailor HBV Reactivation Monitoring in Patients With Solid Tumours—Authors' Reply

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 5, Page 768-769, March 2026.
Hans L. Tillmann, Shiva Poola, MaryKate Kratzer   +2 more
wiley   +1 more source

Epstein–Barr Virus and Hepatitis E Virus in an Immunocompetent Adult: A Rare Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Epstein–Barr virus (EBV) and Hepatitis E virus (HEV) are two distinct viral pathogens known to affect the liver. While EBV commonly causes mild, self‐limited hepatitis, and HEV is the leading cause of acute viral hepatitis globally, co‐infection with both viruses is exceedingly rare.
Philippe Attieh, Antonio Al Hazzouri, Karam Karam, Ihab I. El Hajj, Elias Fiani   +4 more
wiley   +1 more source

A Phase 1, Randomized, Open‐Label, Parallel Group Study to Evaluate the Relative Bioavailability and Safety of Subcutaneous Bepirovirsen when Delivered from a Vial or Prefilled Syringe Fitted with a Safety Syringe Device in Healthy Adult Participants

Clinical Pharmacology in Drug Development, Volume 15, Issue 2, February 2026.
Abstract Bepirovirsen, an antisense oligonucleotide in development for the treatment of chronic hepatitis B virus (HBV) infection, is administered from glass vials as a subcutaneous (SC) injection by healthcare professionals (HCPs). A ready‐to‐use prefilled syringe (PFS) assembled with a safety syringe device (SSD) has been developed to make ...
Amir S. Youssef, Poonam Shah, Maxwell Hu, Helene Plein, Abhishek Roy, Ravi Sharma, Sarah Mole, Magdalena Blazejczyk, Wendy Cross, Brian Spears, Samuel Pak, Rejbinder Kaur, Robert Elston, Dickens Theodore, Marjan Hezareh, Ahmed Nader   +15 more
wiley   +1 more source

Prevalence of HBV DNA in anti-HBe+ chronic HBV carriers in Babol, 2002

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2004
Background and Objective: One of the most important mutations, which occur in hepatitis B virus, is precore mutant. This mutation is associated with highly productive infection in anti-HBe+ chronic HBV carriers. These chronic HBV carriers are predisposed
MR Hassanjani Roshan, MJ Soleimani, A Asghar Zadeh Ahmadi   +2 more
doaj  

High Prevalence of Active HDV Infection Among HBsAg‐Positive Patients in Urban and Rural Areas in Gabon: A Cross‐Sectional Retrospective Study

Health Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background HDV, a defective virus dependent on hepatitis B for assembly, can lead to severe liver diseases and an increased risk of progressing to complications such as hepatocellular carcinoma. Given the high prevalence of HDV in Gabon, especially in central Africa, understanding the epidemiology and associated risks is crucial.
Berthold Bivigou‐Mboumba, Michelle Bignoumba, Pamela Moussavou‐Boundzanga, Elsa‐Luce Missoni Manga, Amahani Gafou, Yann Mouanga Ndzime, Dorothée Marielle Wora, Larissa F. Akombi, Jovanie‐Dawen's Lendoye Zika Olembi, Rejane Manelle Betty Ndjila, Cyrille Bisseye, Augustin Mouinga Ondeme, Richard Onanga, Pascal Pineau   +13 more
wiley   +1 more source

CRISPR/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients. [PDF]

Emerg Microbes Infect, 2023
Tian Y, Fan Z, Xu L, Cao Y, Chen S, Pan Z, Gao Y, Li H, Zheng S, Ma Y, Duan Z, Zhang X, Ren F.   +12 more
europepmc   +1 more source

Genetic variants underlying precancerous conditions of hepatocellular carcinoma

International Journal of Cancer, Volume 158, Issue 3, Page 488-502, 1 February 2026.
Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for 80% of cases worldwide. While chronic hepatitis B and C infections remain primary risk factors, emerging evidence highlights the increasing contributions of metabolic dysfunction‐associated steatotic liver disease (MASLD) and alcohol‐associated liver disease
Jonathan Jaime G. Guerrero, Paolo C. Encarnacion, Mark Angelo S. del Rosario, Matthew Aldren S. Ora, Jiayan Zhou, Kin Israel Notarte, Wan‐Chun Li, Ching‐Wen Chang   +7 more
wiley   +1 more source